Cryptotanshinone attenuates the stemness of non-small cell lung cancer cells via promoting TAZ translocation from nuclear to cytoplasm
Abstract Background Cancer stem cells (CSCs) are regarded as the root of tumor progression, thus representing an anti-cancer therapy through targeting this cell sub-population. Methods Non-small cell lung cancer (NSCLC) CSCs were enriched by non-adherent spheroid formation analysis. Lentivirus infec...
Main Authors: | Linling Jin, Zhenzhen Wu, Yanli Wang, Xin Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Chinese Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13020-020-00348-4 |
Similar Items
-
Yap/Taz inhibit goblet cell fate to maintain lung epithelial homeostasis
by: Julia Hicks-Berthet, et al.
Published: (2021-07-01) -
Regulation of TAZ in cancer
by: Xin Zhou, et al.
Published: (2016-07-01) -
YAP/TAZ Activation as a Target for Treating Metastatic Cancer
by: Janine S. A. Warren, et al.
Published: (2018-04-01) -
YAP/TAZ: a promising target for squamous cell carcinoma treatment
by: Dong X, et al.
Published: (2019-07-01) -
New insights into YAP/TAZ nucleo‐cytoplasmic shuttling: new cancer therapeutic opportunities?
by: Michal Shreberk‐Shaked, et al.
Published: (2019-06-01)